The clinic study of epidural anesthesia with optimal administration of ropivacaine combined with general anesthesia in eld patients undergoing major abdominal surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001678

Enrollment

Unknown

Registered

2014-09-21

Start date

2009-10-09

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anesthology

Interventions

1:0.15% ropivacaine

2:0.375% ropivacaine

3:0.15%+0.375% ropiva

Eligibility

Sex/Gender

Male

Age

65 Years to 81 Years

Inclusion criteria

Inclusion criteria: All patients with a history of central nervous system disorder, hyperthyreosis,hypothyroidism,clinically significant cardiac arrhythmia (frequent ventricular premature beat, fibrillation atrial, atrioventricular block, sinus bradycardia), serious impairment of renal and hepar function,hypertension (systolic pressure >=170 mmHg, or diastolic pressure >=100mmHg), anemia(hemoglobin 30)were excluded from this study.

Exclusion criteria

Exclusion criteria: Patients combined epidural puncture contraindication(such as coagulation disorders and major vertebral abnormalities),bleeding exceed 300 ml in 15min during operation or had a history of taking any kind of analgesic medication were also not included in this study.

Design outcomes

Primary

Measure	Time frame
blood pressure;heart rate;the total dose of remifentanil;	—

Countries

China

Contacts

Public ContactQing-he ZHOU

jiaxingxiaoma@yahoo.cn+86 13732573379

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026